AstraZeneca cancer drug carries toxic risks: FDA
Tuesday, November 30, 2010 - 19:00
in Health & Medicine
An experimental drug developed by AstraZeneca to treat a rare form of thyroid cancer carries "substantial toxicity" risks, the US Food and Drug Administration warned Tuesday.